Dr. Calvo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
National Institutes of Health Clinical Center
10 Center Dr Bldg 10 Rm 2C306
Bethesda, MD 20892Phone+1 301-594-9578- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2008- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2003 - 2006
University of California San Diego School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2006 - 2024
MD State Medical License 2004 - 2024- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.Ifeyinwa E Obiorah, Kalpana D Upadhyaya, Katherine R Calvo> ;Clinics in Laboratory Medicine. 2023 Dec 1
- Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).Rashmi Kanagal-Shamanna, Kristian T Schafernak, Katherine R Calvo> ;Seminars in Diagnostic Pathology. 2023 Nov 1
- How I diagnose myeloid neoplasms with germline predisposition.Nisha Patel, Katherine R Calvo> ;American Journal of Clinical Pathology. 2023 Oct 3
- Join now to see all
Abstracts/Posters
- Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia VariantKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single-Cell RNA Sequencing Reveals a Distinct Transcriptome Signature of Hematopoiesis in GATA2 DeficiencyKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- GATA2-Dependent Developmental and Regenerative NetworksKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term D...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
